AYTU BIOPHARMA, INC Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q3 2018 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Aytu Biopharma, Inc annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q3 2018 to Q3 2023.
- Aytu Biopharma, Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending September 30, 2023 was $1.36M, a 141% increase year-over-year.
- Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $4.04M, a 5.96% increase from 2023.
- Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.81M, a 21.1% increase from 2022.
- Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $3.15M, a 152% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)